AU7404800A - A method for preparing conjugates between an antigen and mucosal binding component - Google Patents

A method for preparing conjugates between an antigen and mucosal binding component

Info

Publication number
AU7404800A
AU7404800A AU74048/00A AU7404800A AU7404800A AU 7404800 A AU7404800 A AU 7404800A AU 74048/00 A AU74048/00 A AU 74048/00A AU 7404800 A AU7404800 A AU 7404800A AU 7404800 A AU7404800 A AU 7404800A
Authority
AU
Australia
Prior art keywords
antigen
binding component
preparing conjugates
mucosal binding
mucosal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74048/00A
Inventor
Are Bogsnes
Karen De Jongh
John Forstrom
Jacob Sten Petersen
Charles R Petrie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU7404800A publication Critical patent/AU7404800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
AU74048/00A 1999-09-30 2000-09-28 A method for preparing conjugates between an antigen and mucosal binding component Abandoned AU7404800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199901392 1999-09-30
DKPA199901392 1999-09-30
PCT/DK2000/000531 WO2001022995A1 (en) 1999-09-30 2000-09-28 A method for preparing conjugates between an antigen and mucosal binding component

Publications (1)

Publication Number Publication Date
AU7404800A true AU7404800A (en) 2001-04-30

Family

ID=8104354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74048/00A Abandoned AU7404800A (en) 1999-09-30 2000-09-28 A method for preparing conjugates between an antigen and mucosal binding component

Country Status (2)

Country Link
AU (1) AU7404800A (en)
WO (1) WO2001022995A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0724360D0 (en) * 2007-12-14 2008-01-23 Glaxosmithkline Biolog Sa Method for preparing protein conjugates
AU2008339093B2 (en) * 2007-12-19 2013-01-24 Toleranzia Ab Compositions and methods for treatment of autoimmune and allergic diseases
CN102459629B (en) 2009-05-19 2019-08-27 迈阿密大学 Composition, kit and method for ex vivo antigen presentation, assessment efficacy of vaccines and assessment biological agent and the immunotoxicity of drug
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
WO2012021512A2 (en) 2010-08-10 2012-02-16 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
RU2654210C2 (en) 2012-03-16 2018-05-17 Мерк Патент Гмбх Targeting aminoacid lipids
WO2015140648A2 (en) 2014-02-21 2015-09-24 Ecole Polytecnique Federale De Lausanne (Epfl) Epfl-Tto Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
CN108912223A (en) * 2018-03-28 2018-11-30 深圳市新产业生物医学工程股份有限公司 Insulin immunogene, preparation method, insulin antibody and kit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194594A (en) * 1990-09-07 1993-03-16 Techniclone, Inc. Modified antibodies
US5545721A (en) * 1992-12-21 1996-08-13 Ophidian Pharmaceuticals, Inc. Conjugates for the prevention and treatment of sepsis
US7097845B2 (en) * 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance

Also Published As

Publication number Publication date
WO2001022995A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU2001282786A1 (en) A sample preparing arrangement and a method
AU4839000A (en) Partial ocr note confirmation methods
AU1352601A (en) A method and apparatus for header compression
AU3227900A (en) Apparatus and method for making a mechanical fastener
AU2001289082A1 (en) Method and system for a lumped-distributed balun
AU2803800A (en) An authentication method
AU3234400A (en) Method for transferring, receiving and utilizing electronic gift certificates
AU2001257306A1 (en) A method and apparatus for integrating tunneling protocols with standard routingprotocols
AU5558799A (en) A mechanical fastener and method for making the same
AU5252396A (en) Method for preparing a modified solid oxide
AU5805500A (en) A method for preparing modified polypeptides
AU4028800A (en) Method for identifying accessible binding sites on rna
AU4106401A (en) Preamble receiving device and preamble receiving method
AU7404800A (en) A method for preparing conjugates between an antigen and mucosal binding component
AU7845300A (en) Book and method for making a book
AU2433501A (en) Binding apparatus
AU2002243272A1 (en) A system and method for validating specifications for parts
AU4116600A (en) A method and device for exciting a luminescent material
AU2002210133A1 (en) Separator assembly for filler device and associated method
AU2001284897A1 (en) Method and system for defining and verifying a part
AU2002227964A1 (en) Pneumatic rock-boring device and method for starting such a device
AU2002218056A1 (en) Method for connecting metallic objects
AU7403000A (en) Method and device for identifying a biopolymer sequence on solid surface
AU3283500A (en) Tumor-associated antigen
AU2001235671A1 (en) Method for preparing a polyaromatic compound

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase